Scott A. Curriden

2.2k total citations
16 papers, 1.9k citations indexed

About

Scott A. Curriden is a scholar working on Cancer Research, Hematology and Immunology and Allergy. According to data from OpenAlex, Scott A. Curriden has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 7 papers in Hematology and 7 papers in Immunology and Allergy. Recurrent topics in Scott A. Curriden's work include Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Cell Adhesion Molecules Research (7 papers). Scott A. Curriden is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Cell Adhesion Molecules Research (7 papers). Scott A. Curriden collaborates with scholars based in United States, Austria and Germany. Scott A. Curriden's co-authors include David J. Loskutoff, Anton Jan van Zonneveld, Ralf‐Peter Czekay, Shaohe Wang, Steven Rosenberg, M Keeton, Kathleen Aertgeerts, Geng Hu, John H. Griffin and Daniel A. Lawrence and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Scott A. Curriden

16 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott A. Curriden United States 14 969 747 650 461 294 16 1.9k
Helene Solberg Denmark 18 930 1.0× 1.0k 1.4× 474 0.7× 290 0.6× 733 2.5× 24 2.4k
Ralf‐Peter Czekay United States 15 747 0.8× 582 0.8× 335 0.5× 318 0.7× 275 0.9× 18 1.5k
Liliana Guédez United States 18 921 1.0× 810 1.1× 299 0.5× 297 0.6× 663 2.3× 22 1.8k
Robert L. Cohen United States 14 840 0.9× 1.2k 1.6× 403 0.6× 264 0.6× 528 1.8× 23 2.2k
Thomas Crabbe United Kingdom 17 1.5k 1.6× 674 0.9× 669 1.0× 332 0.7× 961 3.3× 20 2.1k
M Seiki Japan 8 1.1k 1.1× 646 0.9× 296 0.5× 346 0.8× 650 2.2× 9 1.6k
David C. Gervasi United States 12 1.4k 1.4× 709 0.9× 421 0.6× 241 0.5× 714 2.4× 12 1.8k
Maria Teresa Masucci Italy 15 1.0k 1.1× 713 1.0× 468 0.7× 310 0.7× 779 2.6× 28 2.2k
Cathleen Conner United States 13 933 1.0× 622 0.8× 436 0.7× 230 0.5× 651 2.2× 15 1.5k
Victoria Stepanova Russia 23 524 0.5× 579 0.8× 339 0.5× 132 0.3× 171 0.6× 45 1.4k

Countries citing papers authored by Scott A. Curriden

Since Specialization
Citations

This map shows the geographic impact of Scott A. Curriden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Curriden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Curriden more than expected).

Fields of papers citing papers by Scott A. Curriden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Curriden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Curriden. The network helps show where Scott A. Curriden may publish in the future.

Co-authorship network of co-authors of Scott A. Curriden

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Curriden. A scholar is included among the top collaborators of Scott A. Curriden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Curriden. Scott A. Curriden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kamikubo, Yuichi, Gerard Kroon, Scott A. Curriden, H. Jane Dyson, & David J. Loskutoff. (2006). The Reduced, Denatured Somatomedin B Domain of Vitronectin Refolds into a Stable, Biologically Active Molecule. Biochemistry. 45(10). 3297–3306. 11 indexed citations
2.
Kamikubo, Yuichi, Gerard Kroon, Scott A. Curriden, et al.. (2004). Disulfide Bonding Arrangements in Active Forms of the Somatomedin B Domain of Human Vitronectin. Biochemistry. 43(21). 6519–6534. 33 indexed citations
3.
Czekay, Ralf‐Peter, Kathleen Aertgeerts, Scott A. Curriden, & David J. Loskutoff. (2003). Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. The Journal of Cell Biology. 160(5). 781–791. 249 indexed citations
4.
Okumura, Yuushi, Yuichi Kamikubo, Scott A. Curriden, et al.. (2002). Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor. Journal of Biological Chemistry. 277(11). 9395–9404. 63 indexed citations
5.
Deng, Gary G., Scott A. Curriden, Geng Hu, Ralf‐Peter Czekay, & David J. Loskutoff. (2001). Plasminogen activator inhibitor‐1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. Journal of Cellular Physiology. 189(1). 23–33. 98 indexed citations
6.
Loskutoff, David J., Scott A. Curriden, Geng Hu, & Gang Deng. (1999). Regulation of cell adhesion by PAI‐1. Apmis. 107(1-6). 54–61. 129 indexed citations
7.
Seiffert, Dietmar, Scott A. Curriden, Dieter E. Jenne, Bernd R. Binder, & David J. Loskutoff. (1996). Differential Regulation of Vitronectin in Mice and Humans in Vitro. Journal of Biological Chemistry. 271(10). 5474–5480. 18 indexed citations
8.
Curriden, Scott A., et al.. (1996). Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?. The Journal of Cell Biology. 134(6). 1563–1571. 404 indexed citations
9.
Lee, Myung‐Shik, Danling Gu, Lili Feng, et al.. (1995). Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1.. PubMed. 147(1). 42–52. 129 indexed citations
10.
Keeton, M, Scott A. Curriden, Anton Jan van Zonneveld, & David J. Loskutoff. (1991). Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.. Journal of Biological Chemistry. 266(34). 23048–23052. 284 indexed citations
11.
Loskutoff, David J. & Scott A. Curriden. (1990). The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis. Annals of the New York Academy of Sciences. 598(1). 238–247. 26 indexed citations
12.
Zonneveld, Anton Jan van, Scott A. Curriden, & David J. Loskutoff. (1988). 239 The type 1 plasminogen activator inhibitor gene: Functional analysis and glucocorticoid regulation of its promoter. Fibrinolysis and Proteolysis. 2. 103–103. 13 indexed citations
13.
Zonneveld, Anton Jan van, Scott A. Curriden, & David J. Loskutoff. (1988). Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.. Proceedings of the National Academy of Sciences. 85(15). 5525–5529. 206 indexed citations
14.
Curriden, Scott A., et al.. (1985). Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.. Proceedings of the National Academy of Sciences. 82(4). 1121–1125. 171 indexed citations
15.
Moffett, John R., Scott A. Curriden, Robert Ertsey, Elizabeth A. Mendiaz, & Ellis Englesberg. (1983). Alanine-resistant mutants of Chinese hamster ovary cells, CHO-K1, producing increases in velocity of proline transport through the A, ASC, and P systems. Somatic Cell and Molecular Genetics. 9(2). 189–213. 19 indexed citations
16.
Curriden, Scott A. & Ellis Englesberg. (1981). Inhibition of growth of proline‐requiring Chinese hamster ovary cells (CHO‐K1) resulting from antagonism by a system amino acids. Journal of Cellular Physiology. 106(2). 245–252. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helene Solberg Breakdown of academic impact, for papers by Ralf‐Peter Czekay Breakdown of academic impact, for papers by Liliana Guédez Breakdown of academic impact, for papers by Robert L. Cohen Breakdown of academic impact, for papers by Thomas Crabbe Breakdown of academic impact, for papers by M Seiki Breakdown of academic impact, for papers by David C. Gervasi Breakdown of academic impact, for papers by Maria Teresa Masucci Breakdown of academic impact, for papers by Cathleen Conner Breakdown of academic impact, for papers by Victoria Stepanova
Rankless by CCL
2026